As Skin Rocks reveals its latest innovation, Caroline Hirons shares her top five tips for limiting hyperpigmentation ...

Studies show in mice show that targeting the metabolic pathways could inhibit the growth of melanoma and combining this ...

Leading companies, such as Incyte Corporation, TWi Biotechnology, Amgen, Pfizer, Arcutis Biotherapeutics, AnaptysBio, and others, are actively advancing promising drug candidates aimed at improving ...

An in-depth look at managing sun damage through in-clinic procedures, lasers, and the right skincare. Plus, experts what sun damage looks like and how to prevent it.

Among the five organo-sulfur compounds, PM appeared to be the most potent inhibitor of melanin formation. The analysis of inhibitory kinetics revealed that PM is a mixed-type inhibitor.

I don’t think it’s a slam dunk.” Johnson said her enthusiasm about SC PD-1/PD-L1 inhibitors is tempered after speaking with the pharmacist at her practice, SCRI Oncology Partners.

Enlicitide decanoate is an investigational oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

Our clinical compound, TT125-802, is an orally available small molecule inhibitor of the bromodomain of CBP/p300 with a differentiated, best-in-class safety profile and activity as single agent in ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

Accropeutics’ drug hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to “accelerate” the TYK2/JAK1 inhibitor’s development.

The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.